Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for screening and identifying spinocerebellar ataxia type 3 (SCA3)/Machado-Joseph disease (MJD) molecular marker MicroRNAs (miRNAs) capable of regulating and controlling expression of ATXN3 gene

A molecular marker and gene expression technology, applied in the field of screening and identification of SCA3/MJD molecular marker miRNAs that can regulate the expression of ATXN3 gene

Inactive Publication Date: 2014-07-16
XIANGYA HOSPITAL CENT SOUTH UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] However, adjustable ATXN3 Construction of screening and identification methods for miRNAs in gene expression, and determination of specific involvement in regulation ATXN3 The miRNAs and their targets of gene expression have not been reported at home and abroad, and further research is needed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for screening and identifying spinocerebellar ataxia type 3 (SCA3)/Machado-Joseph disease (MJD) molecular marker MicroRNAs (miRNAs) capable of regulating and controlling expression of ATXN3 gene
  • Method for screening and identifying spinocerebellar ataxia type 3 (SCA3)/Machado-Joseph disease (MJD) molecular marker MicroRNAs (miRNAs) capable of regulating and controlling expression of ATXN3 gene
  • Method for screening and identifying spinocerebellar ataxia type 3 (SCA3)/Machado-Joseph disease (MJD) molecular marker MicroRNAs (miRNAs) capable of regulating and controlling expression of ATXN3 gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0062] The present invention will be further described below in conjunction with the accompanying drawings and embodiments.

[0063] refer to Figure 1~Figure 8 :

[0064] (1) Prepare 5-10ml of anticoagulant blood containing SCA3 / MJD and anticoagulant blood without SCA3 / MJD, separate the serum and store it at -80°C for later use;

[0065] (2) TRIzol method extraction step (1) Total RNAs containing miRNA in serum:

[0066] Take out the serum from the -80°C refrigerator, and after thawing, take 0.25ml of each serum sample and 2~8ul polypropylene carrier, mix it with 0.75ml TRI Reagent BD, close the cap tightly, shake it by hand, and mix the mixture Incubate at room temperature for 5 minutes; add 0.2ml of chloroform to the mixture, cap the tube tightly, and shake vigorously for 15 seconds. Let stand at room temperature for 5 minutes, centrifuge at 12,000 g at 4°C for 15 minutes, and the mixture is divided into three layers, the lower layer is a red phenol-chloroform phase,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The screening and identification method of SCA3 / MJD molecular marker miRNAs that can regulate the expression of ATXN3 gene, including: using miRNA microarray chip technology to obtain the differential expression profile of miRNAs, and using bioinformatics methods and qRT-PCR technology to further screen and verify, and obtain a reliable miRNAs that regulate the expression of ATXN3 gene; use qRT-PCR technology and Western blot technology to determine the targeting relationship and mechanism of miRNAs and ATXN3; use dual luciferase reporter gene detection technology to determine the targeting relationship between miR-25 and ATXN3 gene and The specific binding site provides a basis for the development of SCA3 / MJD disease-related diagnostic kits.

Description

technical field [0001] The present invention relates to a controllable ATXN3 Screening and identification methods of SCA3 / MJD molecular marker miRNAs expressed by genes. Background technique [0002] Spinocerebellar ataxia (Spinocerebellar ataxia, SCA) is one of the main neurodegenerative diseases in humans, among which spinocerebellar ataxia type 3 (Spinocerebellar ataxia type 3 / Machado-Joseph disease, SCA3 / MJD) is the most common. disease-causing gene ATXN3 (MJD1) The encoded protein ataxin-3 is a cytoplasmic protein containing polyglutamine (polyQ). Ataxin-3 proteins containing abnormally extended polyQ peptide chains can selectively accumulate in specific areas of the nervous system (cerebellum, brainstem, spinal cord, etc.) to form neuronal intranuclear inclusions (NIIs) and cause neuronal death. The current research has confirmed that the cytotoxicity of abnormally expanded polyQ mutant proteins triggers the occurrence and development of such diseases. Although th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/68C12N15/11
Inventor 江泓黄凤珍张莉师玉亭唐北沙
Owner XIANGYA HOSPITAL CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com